The association of PNPLA3 variants with liver enzymes in childhood obesity is driven by the interaction with abdominal fat

PLoS ONE

Volumn 6, Issue 11, 2011, Pages

  Miraglia del Giudice, Emanuele ^a   Grandone, Anna ^a   Cirillo, Grazia ^a   Santoro, Nicola ^b   Amato, Alessandra ^a   Brienza, Carmine ^a   Savarese, Piera ^a   Marzuillo, Pierluigi ^a   Perrone, Laura ^a  

^a SECOND UNIVERSITY OF NAPLES   (Italy)

^b YALE UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ASPARTATE AMINOTRANSFERASE; LIVER ENZYME;

ABDOMINAL FAT; ADOLESCENT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ALLELE; ARTICLE; ASPARTATE AMINOTRANSFERASE BLOOD LEVEL; BODY MASS; CHILD; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; DISEASE COURSE; DNA POLYMORPHISM; FEMALE; GENE; GENE FUNCTION; GENE INTERACTION; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE ENVIRONMENT INTERACTION; HOMOZYGOSITY; HUMAN; INSULIN RESISTANCE; LIVER INJURY; MAJOR CLINICAL STUDY; MALE; OBESITY; PNPLA3 GENE; PRESCHOOL CHILD; RISK ASSESSMENT; RISK FACTOR; SCHOOL CHILD; WAIST CIRCUMFERENCE;

ABDOMINAL FAT; ALANINE TRANSAMINASE; CHILD; FEMALE; GENETIC ASSOCIATION STUDIES; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LIPASE; LIVER; MALE; MEMBRANE PROTEINS; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; RISK FACTORS;

EID: 82155164171     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0027933     Document Type: Article

References (41)

1. Iaso-Iotf website. Available: http://www.iaso.org/iotf/obesity/?map=children Accessed Jul 1.
2. Roberts EA, (2007) Non-alcoholic steatohepatitis in children. Clin Liver Dis 11: 155-72.
3. Wieckowska A, McCullough AJ, Feldstein AE, (2007) Noninvasive diagnosis and monitoring of nonalcoholic steatohepatitis: present and future. Hepatology 46: 582-9.
4. Feldstein AE, Charatcharoenwitthaya P, Treeprasertsuk S, Benson JT, Enders FB, et al. (2009) The natural history of non-alcoholic fatty liver disease in children: a follow-up study for up to 20 years. Gut 58: 1538-44.
5. Roden M, (2006) Mechanisms of Disease: hepatic steatosis in type 2 diabetes-pathogenesis and clinical relevance. Nat Clin Pract Endocrinol Metab 2: 335-48.
6. Day CP, (2006) From fat to inflammation. Gastroenterology 130: 207-10.
7. Manco M, Bedogni G, Marcellini M, Devito R, Ciampalini P, et al. (2008) Waist circumference correlates with liver fibrosis in children with non-alcoholic steatohepatitis. Gut 57: 1283-7.
8. Day CP, (2004) The potential role of genes in nonalcoholic fatty liver disease. Clin Liver Dis 8: 673-91.
9. Romeo S, Kozlitina J, Xing C, Pertsemlidis A, Cox D, Pennacchio LA, et al. (2008) Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease. Nat Genet 40: 1461-5.
10. Yuan X, Waterworth D, Perry JR, Lim N, Song K, et al. (2008) Population-based genome-wide association studies reveal six loci influencing plasma levels of liver enzymes. Am J Hum Genet 83: 520-8.
11. Wilson PA, Gardner SD, Lambie NM, Commans SA, Crowther DJ, (2006) Characterization of the human patatin-like phospholipase family. J Lipid Res 47: 1940-9.
12. He S, McPhaul C, Li JZ, Garuti R, Kinch L, et al. (2010) A sequence variation (I148M) in PNPLA3 associated with nonalcoholic fatty liver disease disrupts triglyceride hydrolysis. J Biol Chem 285: 6706-15.
13. Valenti L, Al-Serri A, Daly AK, Galmozzi E, Rametta R, et al. (2010) Homozygosity for the patatin-like phospholipase-3/adiponutrin I148M polymorphism influences liver fibrosis in patients with nonalcoholic fatty liver disease. Hepatology 51: 1209-17.
14. Speliotes EK, Butler JL, Palmer CD, Voight BF, GIANT Consortium (2010) PNPLA3 variants specifically confer increased risk for histologic non-alcoholic fatty liver disease but not metabolic disease. Hepatology 52: 904-12.
15. Valenti L, Alisi A, Galmozzi E, Bartuli A, Del Menico B, et al. (2010) I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease. Hepatology 52: 1274-80.
16. Rotman Y, Koh C, Zmuda JM, Kleiner DE, Liang TJ, et al. (2010) The association of genetic variability in patatin-like phospholipasedomain-containing protein 3 (PNPLA3) with histological severity of non-alcoholic fatty liver disease. Hepatology 52: 894-903.
17. Browning JD, Cohen JC, Hobbs HH, (2010) Patatin-like phospholipase domain-containing 3 and the pathogenesis and progression of pediatric nonalcoholic fatty liver disease. Hepatology 52: 1189-92.
18. Romeo S, Sentinelli F, Dash S, Yeo GS, Savage DB, et al. (2010) Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent. Int J Obes 34: 190-4.
19. Cole TJ, (1990) The LMS method for constructing normalized growth standards. Eur J Clin Nutr 44: 45-60.
20. Tanner JM, Whitehouse RH, (1976) Clinical longitudinal standards for height, weight, height velocity, weight velocity, and stages of puberty. Arch Dis Child 51: 170-9.
21. Lohman TG, Roche AF, Martorell R, (1988) Antropometric standardization reference manual; Human Kinetic Books, Champaign, IL.
22. Strauss RS, Barlow SE, Dietz WH, (2000) Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents. J Pediatr 136: 727-33.
23. Matsuda M, DeFronzo RA, (1999) Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp. Diabetes Care 22: 1462-70.
24. Yeckel CW, Weiss R, Dziura J, Taksali SE, Dufour S, et al. (2004) Validation of insulin sensitivity indices from oral glucose tolerance test parameters in obese children and adolescents. J Clin Endocrinol Metab 89: 1096-101.
25. Paré G, Cook NR, Ridker PM, Chasman DI, (2010) On the use of variance per genotype as a tool to identify quantitative trait interaction effects: a report from the Women's Genome Health Study. PLoS Genet 6: e1000981.
26. Romeo S, Sentinelli F, Cambuli VM, Incani M, Congiu T, et al. (2010) The 148M allele of the PNPLA3 gene is associated with indices of liver damage early in life. J Hepatol 53: 335-8.
27. Kantartzis K, Peter A, Machicao F, Machann J, Wagner S, et al. (2009) Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene. Diabetes 58: 2616-23.
28. Santoro N, Kursawe R, D'Adamo E, Dykas DJ, Zhang CK, et al. (2010) A common variant in the patatin-like phospholipase 3 gene (PNPLA3) is associated with fatty liver disease in obese children and adolescents. Hepatology 52: 1281-90.
29. Maffeis C, Banzato C, Talamini G, Obesity Study Group of the Italian Society of Pediatric Endocrinology and Diabetology (2008) Waist-to-height ratio, a useful index to identify high metabolic risk in overweight children. J Pediatr 52: 207-13.
30. Savva SC, Tornaritis M, Savva ME, Kourides Y, Panagi A, et al. (2000) Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index. Int J Obes Relat Metab Disord 24: 1453-8.
31. Hara M, Saitou E, Iwata F, Okada T, Harada K, (2002) Waist-to-height ratio is the best predictor of cardiovascular disease risk factors in Japanese schoolchildren. J Atheroscler Thromb 9: 127-32.
32. McCarthy HD, Ashwell M, (2006) A study of central fatness using waist-to-height ratios in UK children and adolescents over two decades supports the simple message-'keep your waist circumference to less than half your height'. Int J Obes 30: 988-92.
33. Ashwell M, Hsieh SD, (2005) Six reasons why the waist-to-height ratio is a rapid and effective global indicator for health risks of obesity and how its use could simplify the international public health message on obesity. Int J Food Sci Nutr 56: 303-7.
34. Després JP, Lemieux I, (2006) Abdominal obesity and metabolic syndrome. Nature 444: 881-7.
35. Hsieh SD, Yoshinaga H, Muto T, (2003) Waist-to-height ratio, a simple and practical index for assessing central fat distribution and metabolic risk in Japanese men and women. Int J Obes Relat Metab Disord 27: 610-6.
36. van der Poorten D, Milner KL, Hui J, Hodge A, Trenell MI, et al. (2008) Visceral fat: a key mediator of steatohepatitis in metabolic liver disease. Hepatology 48: 449-57.
37. Zou C, Ma J, Wang X, Guo L, Zhu Z, et al. (2007) Lack of Fas antagonism by Met in human fatty liver disease. Nat Med 13: 1078-85.
38. Wieckowska A, Zein NN, Yerian LM, Lopez AR, McCullough AJ, et al. (2006) In vivo assessment of liver cell apoptosis as a novel biomarker of disease severity in nonalcoholic fatty liver disease. Hepatology 44: 27-33.
39. Abate N, Garg A, Peshock RM, Stray-Gundersen J, Grundy SM, (1995) Relationships of generalized and regional adiposity to insulin sensitivity in men. J Clin. Invest 96: 88-98.
40. Chandalia M, Lin P, Seenivasan T, Livingston EH, Snell PG, et al. (2007) Insulin resistance and body fat distribution in south asian men compared to caucasian men. PLoS ONE 8: e812.
41. Baumeister SE, Völzke H, Marschall P, John U, Schmidt CO, et al. (2008) Impact of fatty liver disease on health care utilization and costs in a general population: a 5-year observation. Gastroenterology 134: 85-94.